{"version":"1.0","type":"link","title":"Real-world effectiveness of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and advanced melanoma at BC Cancer.","author_name":"Yu R 외","author_url":"https://prs-insight.online/author/Yu%20R","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167848","thumbnail_width":1200,"thumbnail_height":630}